patent for semaglutide Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. π Demand GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Semaglutide Patent Expiry in 2026:
Pay in 4 interest-free payments of $6.95 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 23 - Oct 28
)
























